Characterization of Immunogenic and Protective Properties of the Modified Variants of the Strain Francisella tularensis 15 NIIEG

Francisella tularensis is an intracellular bacterium that causes tularemia. Progress in creating a safe and effective vaccine for the prevention of tularemia is challenging due to a lack of knowledge about immunological parameters indicative of protective adaptive immunity. Objective of the research was to assess the effect of modifications of the F. tularensis 15 NIIEG genome on the immunogenic and protective properties of F. tularensis 15/23-1ΔrecA and F. tularensis 15/23-1/sodBΔrecA strains. Materials and methods. Multi-parameter flow cytometry and the measurement of secreted cytokines were used to characterize the responses of mouse spleen lymphocytes in response to re-stimulation of F. tularensis with acid-insoluble complex (AIC) in vitro. Also, the titers of specific antibodies to F. tularensis lipopolysaccharide in blood serum were analyzed by enzyme-linked immunosorbent assay. Results and discussion. It has been shown that immunization with the studied strains led to a significant increase in CD4+ and/or CD8+ T cells capable of expressing functional markers: CD69, CD25 and/or CD28; an increase in the subpopulation of T-helpers synthesizing IFN-γ. In the body of immune mice, a pool of B-lymphocytes was formed, capable of secreting IFN-γ in response to their stimulation with AIC. Immunization with the strain 15/23-1/sodBΔrecA provided 70% protection in mice from intranasal infection with a virulent strain of F. tularensis SchuS4. More pronounced protective properties were associated with the activation of not only B-lymphocytes and T-helpers, but also with the simultaneous activation of cytotoxic T-lymphocytes.

1. Olsuf’ev N.G. [Taxonomy, Microbiology, and Laboratory Diagnostics of Tularemia Agent]. Moscow: “Meditsina”; 1975. 192 p.

2. Dyatlov I.A., editor. [Tularemia: status of the issue and methods of study]. Moscow: “Dinastiya”; 2019. 263 p.

3. Mokrievich A.N., Vakhrameeva G.M., Titareva G.M., Bakhteeva I.V., Mironova R.I., Kombarova T.I., Kravchenko T.B., Dyatlov I.A., Pavlov V.M. [Production and immunobiological properties of the vaccine strain of tularemia microbe without one copy of iglC gene and recA gene]. Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya [Molecular Genetics, Microbiology, and Virology] 2015; 33(3):33–9.

4. Sukhova M.A., Vakhrameeva G.M., Kravchenko T.B., Mokrievich A.N., Pavlov V.M., Dyatlov I.A. [Constructing and studies of properties of Francisella tularensis 15 NIIEG strain variants with attenuated expression of sodB gene encoding Fesuperoxiddismutase]. Biotekhnologiya [Biotechnology]. 2015; 31(4):16–27.

5. Volokh O.A., Kuznetsova E.M., Smol’kova E.A., Shchukovskaya T.N., Bugorkova S.A., Avdeeva N.G., Filimonova D.G., Shmel’kova T.P., Klyueva S.N., Nikiforov A.K. [Experimental preparation for specific prophylaxis of tularemia]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2013; 2:73–7. DOI: 10.21055/0370-1069-2013-2-73-77.

6. Somov A.N., Kravchenko T.B., Pavlov V.M., Vakhrameeva G.M., Kombarova T.I., Mironova R.I., Firstova V.V., Kalmantaeva O.V., Vetchinin S.S., Mokrievich A.N. [Antigen and immunogenic properties of acid-insoluble complex of Francisella tularensis 15 NIIEG in soluble, adsorbed, and micro-capsular entities]. Biotekhnologiya [Biotechnology]. 2017; 33(5):23–34. DOI: 10.21519/0234-2758-2017-33-5-23-34.

7. Roberts L.M., Powell D.A., Frelinger J.A. Adaptive immunity to Francisella tularensis and considerations for vaccine development. Front. Cell. Infect. Microbiol. 2018; 8:115. DOI: 10.3389/fcimb.2018.00115.

8. Crane D.D., Scott D.P., Bosio C.M. Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One. 2012; 7:e33349. DOI: 10.1371/journal.pone.0033349.

9. Hurdayal R., Ndlovu H.H., Revaz-Breton M., Parihar S.P., Nono J.K., Govender M., Brombacher F. IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases. Proc. Natl. Acad. Sci. USA. 2017; 114(40):E8430–E8439. DOI: 10.1073/pnas.1708125114.

10. Wojciechowski W., Harris D.P., Sprague F., Mousseau B., Makris M., Kusser K., Honjo T., Mohrs K., Mohrs M., Randall T., Lund F.E. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity. 2009; 30(3):421–33. DOI: 10.1016/j.immuni.2009.01.006.

11. Elkins K.L., Bosio C.M., Rhinehart-Jones T.R. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect. Immun. 1999; 67(11):6002–7. DOI: 10.1128/IAI.67.11.6002-6007.1999.

12. Vega-Ramos J., Alari-Pahissa E., Valle J.D., Carrasco-Marín E., Esplugues E., Borràs M., Martínez-A C., Lauzurica P. CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection. Immunol. Cell Biol. 2010; 88(7):707–15. DOI: 10.1038/icb.2010.62.

13. Amu S., Gjertsson I., Brisslert M. Functional characterization of murine CD25 expressing B cells. Scand. J. Immunol. 2010; 71(4):275–82. DOI: 10.1111/j.1365-3083.2010.02380.x.

14. Culkin S.J., Rhinehart-Jones T., Elkins K.L. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 1997; 158(7):3277–84. PMID: 9120284.

15. Elkins K.L., Cowley S.C., Bosio C.M. Innate and adaptive immunity to Francisella. Ann. N Y Acad. Sci. 2007; 1105:284–324. DOI: 10.1196/annals.1409.014.

16. Cowley S.C., Elkins K.L. Immunity to Francisella. Front. Microbiol. 2011; 2:26. DOI: 10.3389/fmicb.2011.00026.

17. Elkins K.L., Kurtz S.L., De Pascalis R. Progress, challenges, and opportunities in Francisella vaccine development. Expert Rev. Vaccines. 2016; 15:(9):1183–96. DOI: 10.1586/14760584.2016.1170601.

18. Beyersdorf N., Kerkau T., Hünig T. CD28 co-stimulation in T-cell homeostasis: a recent perspective. Immunotargets Ther. 2015; 4:111–22. DOI: 10.2147/ITT.S61647.

19. Kartseva A.S., Silkina M.V., Kalmantaeva O.V., Mironova R.I., Firstova V.V., Pavlov V.M., Shemyakin I.G. [Comparison of early immune response of mice vaccinated with tularemia vaccine strain and its derivatives]. Rossiisky Immunologichesky Zhurnal [Russian Immunological Journal]. 2019; 22(3):1177–82.

20. Roberts L.M., Crane D.D., Wehrly T.D., Fletcher J.R., Jones B.D., Bosio C.M. Inclusion of epitopes that expand high-avidity CD4+ T cells transforms subprotective vaccines to efficacious immunogens against virulent Francisella tularensis. J. Immunol. 2016; 197(7):2738–47. DOI: 10.4049/jimmunol.1600879.